Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Ajay_Piramal
|
| gptkbp:country |
gptkb:India
|
| gptkbp:founded |
1988
|
| gptkbp:founder |
gptkb:Ajay_Piramal
|
| gptkbp:headquarters |
gptkb:Mumbai
|
| https://www.w3.org/2000/01/rdf-schema#label |
Piramal Enterprises
|
| gptkbp:industry |
Financial Services
Pharmaceuticals |
| gptkbp:keyPerson |
gptkb:Nandini_Piramal
gptkb:Peter_DeYoung gptkb:Ajay_Piramal |
| gptkbp:listedOn |
gptkb:NSE
BSE |
| gptkbp:numberOfEmployees |
over 10,000
|
| gptkbp:parentCompany |
gptkb:Piramal_Group
|
| gptkbp:product |
gptkb:Healthcare_Insights_&_Analytics
Financial Services Pharmaceuticals |
| gptkbp:revenue |
INR 6,646 crore (FY 2023)
|
| gptkbp:stockExchange |
gptkb:NSE
BSE |
| gptkbp:stockSymbol |
gptkb:PEL
|
| gptkbp:subsidiary |
gptkb:Piramal_Pharma
|
| gptkbp:website |
https://www.piramal.com/
|
| gptkbp:bfsParent |
gptkb:S._Ramadorai
|
| gptkbp:bfsLayer |
5
|